SMTL ID : 2rg5.1

Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11B

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x 279: N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide(Non-covalent)

279.1: 19 residues within 4Å: Chain A: V.44, A.57, K.59, E.77, L.81, I.90, L.110, T.112, H.113, L.114, M.115, G.116, A.117, D.118, A.163, L.173, D.174, F.175, L.177 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:A.57, A:K.59, A:L.81, A:I.90, A:T.112, A:M.115, A:A.163, A:L.173 Hydrogen bonds: A:E.77, A:E.77, A:M.115, A:D.174 pi-Cation interactions: A:K.59

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hynes, J. et al., Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha Mitogen-Activated Protein Kinase Inhibitors. J.Med.Chem. (2008)

Release Date

2008-01-15

Peptides

Mitogen-activated protein kinase 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 14

Related Entries With Identical Sequence